Role of circulating angiotensin converting enzyme 2 in left ventricular remodeling following myocardial infarction: a prospective controlled study.
Angiotensin-converting enzyme 2 (ACE2) cleaves Angiotensin-II to Angiotensin-(1-7), a cardioprotective peptide. Serum soluble ACE2 (sACE2) activity is raised in chronic heart failure, suggesting a compensatory role in left ventricular dysfunction. Our aim was to study the relationship between sACE2...
Guardado en:
Autores principales: | José T Ortiz-Pérez, Marta Riera, Xavier Bosch, Teresa M De Caralt, Rosario J Perea, Julio Pascual, María José Soler |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2013
|
Materias: | |
Acceso en línea: | https://doaj.org/article/146d8cc4ed65450cb6106b63fc88e0bc |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Circulating biomarkers as predictors of left ventricular remodeling after myocardial infarction
por: Michał Węgiel, et al.
Publicado: (2021) -
Left ventricular pseudoaneurysm as a complication of myocardial infarction
por: Gonçalo Miranda, et al.
Publicado: (2021) -
Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers: Anti-arrhythmic Drug for Arrhythmogenic Right Ventricular Cardiomyopathy
por: Bin Tu, et al.
Publicado: (2021) -
Left ventricular systolic dysfunction among nocturnal myocardial infarctions
por: A Ghaemian, et al.
Publicado: (2004) -
Serum MMP-8: a novel indicator of left ventricular remodeling and cardiac outcome in patients after acute myocardial infarction.
por: Marie Fertin, et al.
Publicado: (2013)